Lipid intervention trials in primary prevention: a critical review.

about

Lipid intervention trials in primary prevention: a critical review.

Item

http://www.wikidata.org/entity/Q35898718

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

Lipid intervention trials in primary prevention: a critical review.

@ast

Lipid intervention trials in primary prevention: a critical review.

@en

type

Item

label

Lipid intervention trials in primary prevention: a critical review.

@ast

Lipid intervention trials in primary prevention: a critical review.

@en

prefLabel

Lipid intervention trials in primary prevention: a critical review.

@ast

Lipid intervention trials in primary prevention: a critical review.

@en

P1476

Lipid intervention trials in primary prevention: a critical review.

@en

P2093

Kaplan NM

http://www.w3.org/2001/XMLSchema#string

P2860

The cholesterol controversy is over. Why did it take so long?

Treating hypercholesterolemia. How should practicing physicians interpret the published data for patients?

Prescribed use of cholesterol-lowering drugs in the United States, 1978 through 1988.

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.

Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey.

Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management.

The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholester

Coronary heart disease is not preventable by population interventions.

Cholesterol reduction and life expectancy. A model incorporating multiple risk factors.

P304

109-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10641969209036175

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1992-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1541031

http://www.w3.org/2001/XMLSchema#string